Patients
0.7 per 100,000 people
Suicide rate, Egypt, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Egypt Opioid Use Disorder Drugs Market Industry Trends and Forecast to 2034: Segmented by (Drug, Formulation, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$12.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $12.3 Mn | — | — |
| 2025 (base) | $13.2 Mn | +$0.9 Mn | — |
| 2026 (forecast) | $14.2 Mn | +$1.0 Mn | +7.5% |
| 2027 (forecast) | $15.2 Mn | +$1.1 Mn | +15.6% |
| 2028 (forecast) | $16.4 Mn | +$1.1 Mn | +24.2% |
| 2029 (forecast) | $17.6 Mn | +$1.2 Mn | +33.5% |
| 2030 (forecast) | $18.9 Mn | +$1.3 Mn | +43.6% |
| 2031 (forecast) | $20.3 Mn | +$1.4 Mn | +54.3% |
| 2032 (forecast) | $21.9 Mn | +$1.5 Mn | +65.9% |
| 2033 (forecast) | $23.5 Mn | +$1.6 Mn | +78.3% |
| 2034 (forecast) | $25.3 Mn | +$1.8 Mn | +91.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $13.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $25.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Drug, formulation and end user (see all) |
| Key players | Indivior, Alkermes, Orexo, Braeburn, Emergent BioSolutions (see all) |
| Regulator in Egypt | EDASource: Egyptian Drug Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Opioid use disorder drugs such as buprenorphine, methadone and naltrexone reduce cravings and overdose risk.
Key segments of the opioid Use Disorder Drugs market include drug (Buprenorphine, Methadone and Naltrexone) and formulation (Sublingual, Extended-Release Injectable and Implants).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the opioid Use Disorder Drugs market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the opioid Use Disorder Drugs market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the opioid Use Disorder Drugs market.
The opioid Use Disorder Drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are registered with the Egyptian Drug Authority (EDA), set up in 2019.[1] A universal health insurance system, set up by Law No. 2 of 2018, is being rolled out governorate by governorate, starting with Port Said in 2019.[2] Suicide rate: 0.7 per 100,000 people in 2023, the latest WHO figure for Egypt.[3]
[1] Egyptian Drug Authority. Checked 14 Nov 2026.
[2] Universal Health Insurance Authority. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 20 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for opioid Use Disorder Drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Egypt.
What doctors and scientists are doing in Opioid Use Disorder Drugs right now, from free public sources.
0.7 per 100,000 people
Suicide rate, Egypt, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
From our blog
Egypt · 1 shared keyword
Egypt
Egypt
Egypt
Egypt
Egypt
OTC & Nutraceuticals · Egypt
Public Health · Egypt
Digital Health · Egypt
Digital Health · Egypt
Public Health · Egypt
OTC & Nutraceuticals · Egypt